Medicare Enrolled

Dr. David Schwimmer, M.D.

Gastroenterology · Palm Beach Gardens, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3401 PGA BLVD STE 500, Palm Beach Gardens, FL 33410
5616596543
In practice since 2014 (11 years)
NPI: 1245641380 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schwimmer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schwimmer? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schwimmer

Dr. David Schwimmer is a gastroenterology specialist in Palm Beach Gardens, FL, with 11 years of NPI registration. Based on federal Medicare data, Dr. Schwimmer performed 13,242 Medicare services across 877 unique beneficiaries.

Between the years covered by Open Payments, Dr. Schwimmer received a total of $9,645 from 40 pharmaceutical and/or device companies across 390 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schwimmer is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ Top 2% volume in FL $9,645 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 132855 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
13,242
Medicare services
Top 2% in FL for gastroenterology
877
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,204 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Vedolizumab infusion (Entyvio)
This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams.
12,300 $17 $43
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
155 $87 $256
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
141 $69 $182
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
137 $77 $410
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
112 $69 $282
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
87 $207 $523
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
74 $68 $227
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
66 $116 $337
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
42 $50 $133
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
32 $88 $363
Upper endoscopy (EGD)
A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope.
27 $90 $251
Endoscopic control of upper GI bleeding
A flexible endoscope is used to locate and stop bleeding in the esophagus, stomach, or upper small intestine.
22 $144 $406
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
22 $129 $379
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $45 $114
Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm
A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length.
11 $102 $315
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
93.2% high complexity
2.3% medium
4.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,645
Total received (2018-2024)
Avg $1,378/year across 7 years
Top 17% in FL for gastroenterology
40
Companies
390
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,545 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,631
2023
$2,441
2022
$2,277
2021
$1,785
2020
$590
2019
$126
2018
$794

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AbbVie Inc.
$1,506
ABBVIE INC.
$1,400
Janssen Biotech, Inc.
$1,173
Takeda Pharmaceuticals U.S.A., Inc.
$760
BOSTON SCIENTIFIC CORPORATION
$724
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$624
Celgene Corporation
$417
QOL Medical, LLC
$407
PFIZER INC.
$250
GENZYME CORPORATION
$220
Nestle HealthCare Nutrition Inc.
$171
INTERCEPT PHARMACEUTICALS, INC.
$150
Ironwood Pharmaceuticals, Inc
$149
E.R. Squibb & Sons, L.L.C.
$140
Braintree Laboratories, Inc.
$140
RedHill Biopharma Inc.
$138
Intercept Pharmaceuticals, Inc.
$138
Olympus America Inc.
$125
Janssen Scientific Affairs, LLC
$86
Regeneron Healthcare Solutions, Inc.
$84
EVOKE PHARMA, INC.
$71
Daiichi Sankyo Inc.
$71
Aries Pharmaceuticals, Inc.
$71
AbbVie, Inc.
$67
Merck Sharp & Dohme LLC
$60
Boston Scientific Corporation
$59
Palette Life Sciences, Inc.
$59
Phathom Pharmaceuticals, Inc.
$49
Fresenius Kabi USA, LLC
$45
Ardelyx, Inc.
$44
UCB, Inc.
$40
VIVUS LLC
$35
Gilead Sciences, Inc.
$32
Amgen Inc.
$26
Pharmacosmos Therapeutics Inc.
$24
IRONWOOD PHARMACEUTICALS, INC
$21
AstraZeneca Pharmaceuticals LP
$20
Ferring Pharmaceuticals Inc.
$18
Lilly USA, LLC
$16
Novo Nordisk Inc
$15
Top 3 companies account for 42.3% of total payments
Associated products mentioned in payments ›
ACQUIRE · ANDEXXA · AVSOLA · Aemcolo · CREON · Cimzia · DIFICID · DISPOSABLE TRIPLE LUMEN SPHINCTEROTOME · DUPIXENT · ELEVIEW · ENTYVIO · GATTEX · GENERAL THERAPIES · GIMOTI · HUMIRA · Humira · IBSRELA · IDACIO · INJECTAFER · LINZESS · Linzess · MAVYRET · MONOFERRIC · MOTOFEN · Movantik · OCALIVA · OMVOH · PANCREAZE · Pancreaze · REMICADE · RINVOQ · SKYRIZI · SOLESTA · SPYGLASS · STELARA · SUCRAID · SUPREP BOWEL PREP · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · VIBERZI · VOQUEZNA · Wegovy · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $73 per 100 Medicare services performed
Looking for a gastroenterology specialist in Palm Beach Gardens?
Compare gastroenterologists in the Palm Beach Gardens area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
73
Per 100K population
4.8
County median income
$81,115
Nearest hospital
PALM BEACH GARDENS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Schwimmer is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), with low-engagement industry engagement in the top 17% of FL peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Schwimmer experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Schwimmer performed 12,300 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schwimmer receive payments from pharmaceutical companies?
Yes. Dr. Schwimmer received a total of $9,645 from 40 companies across 390 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schwimmer's costs compare to other gastroenterologists in Palm Beach Gardens?
Dr. Schwimmer's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schwimmer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →